MNKD – mannkind corporation (US:NASDAQ)

News

How The MannKind (MNKD) Story Is Shifting As Tyvaso Risks Meet Afrezza And Furoscix Potential [Yahoo! Finance]
MannKind: Strategic Uncertainty Follows United Therapeutics' Pivot (Rating Downgrade) [Seeking Alpha]
MannKind (MNKD) was downgraded by Zacks Research from "hold" to "strong sell".
MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
MannKind CEO purchases 100,000 shares; stock climbs [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com